IRADIMED CORPORATION (FRA:46K)
Germany · Delayed Price · Currency is EUR 79.50
+0.50 (0.63%)
At close: Nov 28, 2025
IRADIMED CORPORATION Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 80.51 | 73.24 | 65.56 | 53.3 | 41.81 | 31.72 | Upgrade | |
Revenue Growth (YoY) | 12.91% | 11.71% | 23.00% | 27.47% | 31.84% | -17.65% | Upgrade |
Cost of Revenue | 18.46 | 16.89 | 15.4 | 12.02 | 9.76 | 8.14 | Upgrade |
Gross Profit | 62.05 | 56.35 | 50.16 | 41.28 | 32.05 | 23.57 | Upgrade |
Selling, General & Admin | 34.49 | 31.59 | 27.3 | 23.41 | 20.36 | 19.76 | Upgrade |
Research & Development | 2.71 | 2.8 | 2.82 | 2.24 | 1.87 | 1.87 | Upgrade |
Operating Expenses | 37.2 | 34.39 | 30.12 | 25.65 | 22.23 | 21.63 | Upgrade |
Operating Income | 24.85 | 21.96 | 20.04 | 15.63 | 9.82 | 1.94 | Upgrade |
Interest & Investment Income | 2.19 | 2.19 | 1.86 | 0.58 | 0.03 | 0.13 | Upgrade |
Currency Exchange Gain (Loss) | -0.04 | -0.04 | -0.15 | -0.04 | -0.03 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | -0.09 | 0.16 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | 26.92 | 24.28 | 21.75 | 16.17 | 9.82 | 2.07 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 0.01 | 0.02 | 0.02 | Upgrade |
Gain (Loss) on Sale of Assets | -0 | -0 | -0.01 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | -2.7 | Upgrade |
Pretax Income | 26.91 | 24.28 | 21.74 | 16.18 | 9.84 | -0.62 | Upgrade |
Income Tax Expense | 5.73 | 5.04 | 4.55 | 3.35 | 0.51 | -1.99 | Upgrade |
Net Income | 21.18 | 19.23 | 17.19 | 12.83 | 9.33 | 1.37 | Upgrade |
Net Income to Common | 21.18 | 19.23 | 17.19 | 12.83 | 9.33 | 1.37 | Upgrade |
Net Income Growth | 13.73% | 11.87% | 34.02% | 37.56% | 581.19% | -85.78% | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 12 | 12 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 12 | Upgrade |
Shares Change (YoY) | 0.68% | 0.48% | 0.69% | 0.36% | 1.21% | 1.33% | Upgrade |
EPS (Basic) | 1.67 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | Upgrade |
EPS (Diluted) | 1.65 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | Upgrade |
EPS Growth | 13.00% | 11.11% | 32.35% | 37.84% | 572.73% | -85.90% | Upgrade |
Free Cash Flow | 14.75 | 17.62 | 6.02 | 9.22 | 10.78 | 5.37 | Upgrade |
Free Cash Flow Per Share | 1.15 | 1.38 | 0.47 | 0.73 | 0.86 | 0.43 | Upgrade |
Dividend Per Share | 0.680 | 0.470 | 0.150 | - | - | - | Upgrade |
Dividend Growth | 51.11% | 213.33% | - | - | - | - | Upgrade |
Gross Margin | 77.07% | 76.94% | 76.50% | 77.45% | 76.65% | 74.33% | Upgrade |
Operating Margin | 30.87% | 29.99% | 30.56% | 29.32% | 23.48% | 6.13% | Upgrade |
Profit Margin | 26.31% | 26.26% | 26.22% | 24.07% | 22.30% | 4.32% | Upgrade |
Free Cash Flow Margin | 18.32% | 24.06% | 9.19% | 17.30% | 25.77% | 16.95% | Upgrade |
EBITDA | 25.83 | 22.78 | 20.8 | 16.3 | 11.22 | 3.28 | Upgrade |
EBITDA Margin | 32.09% | 31.11% | 31.73% | 30.58% | 26.84% | 10.35% | Upgrade |
D&A For EBITDA | 0.98 | 0.82 | 0.77 | 0.67 | 1.41 | 1.34 | Upgrade |
EBIT | 24.85 | 21.96 | 20.04 | 15.63 | 9.82 | 1.94 | Upgrade |
EBIT Margin | 30.87% | 29.99% | 30.56% | 29.32% | 23.48% | 6.13% | Upgrade |
Effective Tax Rate | 21.29% | 20.77% | 20.91% | 20.72% | 5.19% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.